Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants

Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimen...

Full description

Bibliographic Details
Main Authors:	Bingjie Wang, Meghan A. Koch
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	Cell Reports Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666379121001671

id	doaj-c6f91abaf84f4c138bbd8c52d281acc7
record_format	Article
spelling	doaj-c6f91abaf84f4c138bbd8c52d281acc72021-06-17T04:48:50ZengElsevierCell Reports Medicine2666-37912021-06-0126100324Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infantsBingjie Wang0Meghan A. Koch1Molecular and Cellular Biology Program and Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USABasic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA; Corresponding authorNecrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.http://www.sciencedirect.com/science/article/pii/S2666379121001671
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Bingjie Wang Meghan A. Koch
spellingShingle	Bingjie Wang Meghan A. Koch Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants Cell Reports Medicine
author_facet	Bingjie Wang Meghan A. Koch
author_sort	Bingjie Wang
title	Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
title_short	Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
title_full	Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
title_fullStr	Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
title_full_unstemmed	Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
title_sort	cytokine therapy in necrotizing enterocolitis: a promising treatment for preterm infants
publisher	Elsevier
series	Cell Reports Medicine
issn	2666-3791
publishDate	2021-06-01
description	Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.
url	http://www.sciencedirect.com/science/article/pii/S2666379121001671
work_keys_str_mv	AT bingjiewang cytokinetherapyinnecrotizingenterocolitisapromisingtreatmentforpreterminfants AT meghanakoch cytokinetherapyinnecrotizingenterocolitisapromisingtreatmentforpreterminfants
_version_	1721374346638786560

Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants

Similar Items